PREVAIL THERAPEUTICS
Startup
PREVAIL THERAPEUTICS
Description
Prevail Therapeutics develops gene therapies designed for targeting the root genetic causes of Parkinson’s disease and other neurodegenerative disorders.
PREVAIL THERAPEUTICS
Address
United States
Contact
info@prevailtherapeutics.com
Description
Prevail Therapeutics develops gene therapies designed for targeting the root genetic causes of Parkinson’s disease and other neurodegenerative disorders.
Matchmaking
Connect with PREVAIL THERAPEUTICS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways